The FDA approved a new generic of valsartan Feb. 12 to help relieve the shortage of the critical blood pressure drug that resulted from a string of recent recalls. Since last summer, several ...

The FDA found a second toxin that may cause cancer in three lots of valsartan, a commonly prescribed drug to control blood pressure and prevent heart failure. Health regulators in the U.S., Canada and ...

The new version is being made by Alkem Laboratories Ltd., based in Mumbai, India. “The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine ...

Policy interventions, including large-scale private-public partnerships, are key to reducing prescription drug shortages and averting patient harm. Shortages of prescription generic drugs, which ...

The U.S. Food and Drug Administration is expanding a recall of drug products containing the ingredient valsartan, which is used to treat high blood pressure and heart failure. The FDA first issued a ...

Sacubitril, valsartan; 6mg/6mg, 15mg/16mg; oral pellets in caps. Entresto Sprinkle is supplied as film-coated oral pellets are round, biconvex in shape, and provided in a hard capsule in the following ...

The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.